Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.555 USD | +1.00% | -2.15% | +74.33% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+74.33% | 3.17B | |
+8.57% | 114B | |
+10.55% | 104B | |
-12.71% | 22.41B | |
-0.32% | 22.28B | |
-5.75% | 19.07B | |
-37.36% | 18B | |
-5.68% | 17.89B | |
+6.98% | 14.28B | |
+36.59% | 12.55B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Transcript : Summit Therapeutics Inc., Q2 2023 Earnings Call, Aug 09, 2023